INNOBIOSCIENCE LLC has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), Canada and Australia. Its main competitors in its focus markets pharmaceuticals are ZUOGUANG ZHANG, NEUROKEY AS and LIPID THERAPEUTICS GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Canada | 2 | |
#3 | Australia | 1 | |
#4 | Chile | 1 | |
#5 | Hong Kong | 1 | |
#6 | Mexico | 1 | |
#7 | New Zealand | 1 | |
#8 | United States | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Hancke Orozco Juan L | 6 |
#2 | Burgos Rafael | 5 |
#3 | Inestrosa Nibaldo C | 4 |
#4 | Hankcke Orozco Juan L | 3 |
#5 | Hancke Juan O | 2 |
#6 | Juan O Hancke | 1 |
Publication | Filing date | Title |
---|---|---|
EP3468553A1 | Andrographolide treats progressive forms of multiple sclerosis | |
WO2014176149A1 | Treatment of alzheimer's and cognitive impairment with andrographolides | |
AU2012359081A1 | Combination therapy with interferon and andrographolides for multiple sclerosis |